Q1 2026 Holdings
Filed 2026-05-15 | 20 holdings | $41.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $29.6M | 524,786 | 70.9% |
| Indivior Pharmaceuticals Inc(INDV) | COM | 45579U109 | $10.3M | 339,532 | 0.0% |
| Biontech SE(BNTX) | ADR | 09075V102 | $5.3M | 59,523 | 12.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $3.7M | 20,000 | 8.8% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $3.0M | 500,000 | 7.2% |
| United Therapeutics Corp(UTHR) | COM | 91307C102 | $50.0K | 84,282 | 0.1% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $36.2K | 2,866,138 | 0.1% |
| Jazz Pharmaceuticals PLC(JAZZ) | COM | G50871105 | $31.7K | 167,816 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $17.8K | 415,693 | 0.0% |
| Sanofi(SNY) | ADR | 80105N105 | $15.6K | 323,946 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $14.5K | 280,681 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $8.2K | 390,879 | 0.0% |
| Vanda Pharmaceuticals Inc(VNDA) | COM | 921659108 | $8.2K | 1,180,388 | 0.0% |
| Embecta Corp(EMBC) | COM | 29082K105 | $6.5K | 735,340 | 0.0% |
| GSK PLC(GSK) | ADR | 37733W204 | $5.3K | 96,729 | 0.0% |
| Alkermes PLC(ALKS) | COM | G01767105 | $3.8K | 107,822 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $3.1K | 4,000 | 0.0% |
| Inmode LTD(INMD) | COM | M5425M103 | $1.7K | 120,942 | 0.0% |
| Evolus Inc(EOLS) | COM | 30052C107 | $649 | 157,985 | 0.0% |
| Abbott Laboratories(ABT) | COM | 002824100 | $513 | 5,000 | 0.0% |